New Ideas and New Treatment Options for Acquired Resistance for ALK/ROS1

from GRACEcast · host cancerGRACE Meetings

Xalkori (critzotinib) was the first approved treatment for ALK+ and ROS1 lung cancer. Since then, other drugs have been approved or are currently undergoing scientific review. In this video, Dr. Owonikoko outlines these options for patients.

Episode metadata supplied by the publisher feed · Published Jan 1, 2016

Embed this episode

Attribution link and audio player

NOW PLAYING

New Ideas and New Treatment Options for Acquired Resistance for ALK/ROS1

0:00 31:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

GRACEcast Radiation Oncology Video cancerGRACE - H. Jack West, MD Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care. GRACEcast - Discussions with the Global Resource for Advancing Cancer Education cancerGRACE In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership. We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis. For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums GRACEcast Lung Cancer Audio cancerGRACE - H. Jack West, MD Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care. GRACEcast Lung Cancer Video cancerGRACE - H. Jack West, MD Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 31 minutes long.

When was this GRACEcast episode published?

This episode was published on January 1, 2016.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!